JPWO2020235587A1 - - Google Patents
Info
- Publication number
- JPWO2020235587A1 JPWO2020235587A1 JP2021520813A JP2021520813A JPWO2020235587A1 JP WO2020235587 A1 JPWO2020235587 A1 JP WO2020235587A1 JP 2021520813 A JP2021520813 A JP 2021520813A JP 2021520813 A JP2021520813 A JP 2021520813A JP WO2020235587 A1 JPWO2020235587 A1 JP WO2020235587A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/72—4,7-Endo-alkylene-iso-indoles
- C07D209/76—4,7-Endo-alkylene-iso-indoles with oxygen atoms in positions 1 and 3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019095359 | 2019-05-21 | ||
| PCT/JP2020/019911 WO2020235587A1 (en) | 2019-05-21 | 2020-05-20 | Tandospirone derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2020235587A1 true JPWO2020235587A1 (en) | 2020-11-26 |
Family
ID=73458313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021520813A Pending JPWO2020235587A1 (en) | 2019-05-21 | 2020-05-20 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2020235587A1 (en) |
| WO (1) | WO2020235587A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63132887A (en) * | 1987-10-27 | 1988-06-04 | Sumitomo Pharmaceut Co Ltd | Novel imide derivative |
| AU6230698A (en) * | 1997-02-26 | 1998-09-18 | Sumitomo Pharmaceuticals Company, Limited | Dopamine d4 receptor antagonist |
-
2020
- 2020-05-20 WO PCT/JP2020/019911 patent/WO2020235587A1/en active Application Filing
- 2020-05-20 JP JP2021520813A patent/JPWO2020235587A1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020235587A1 (en) | 2020-11-26 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210811 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230407 |